Press

Latest StemoniX News

  • Dec, 1

    StemoniX selected for a Connect Most Innovative Product Award The competition, in its 30th year, highlights some of the key innovations occurring in the San Diego technology community. Connect, a local start-up accelerator and educator, organizes the contest. It honored winners in 10 categories from defense technology to medical devices at a ceremony Thursday in […]

    Read more
    Nov, 30

    StemoniX Selected as a 2017 Red Herring Top 100 Global Winner Pasadena, California — Red Herring announced its Top 100 Global in recognition of the leading private companies from North America, Europe, and Asia, celebrating these startups’ innovations and technologies across their respective industries. Red Herring’s Top 100 Global list has become a mark of […]

    Read more
  • Nov, 15

    18th annual Tekne Awards recognized Minnesota’s technology innovators and innovations 2017 Tekne Awards   Minneapolis, MN, 15 November 2017 — The Minnesota High Tech Association (MHTA) has named StemoniX, Inc. as the recipient of the 2017 Tekne Award in the Start Up award category. Held November 15 at the Minneapolis Convention Center, the Tekne Awards […]

    Read more
    Jul, 19

    – Minneapolis, MN Pairnomix Teams Up With StemoniXTo Co-Develop New Epilepsy Model Pairnomix, LLC, a personalized genetic evaluations company, and StemoniX today announced a new strategic partnership. The partnership will combine Pairnomix’s expertise in epilepsy modeling with StemoniX’s proprietary microBrain® technology to create a new in vitro seizure-in-a-dish model system. Human induced pluripotent stem cell […]

    Read more
  • Jul, 13

    – Minneapolis, MN Stemonix looks to eliminate ‘guinea pig medicine’ Stemonix products allow doctors to see how drugs and human cells react without risking a person’s health. Ping Yeh fought a tough battle with blood cancer and survived, but the effects linger five years later. Yeh is cancer-free, but he still deals with side effects […]

    Read more
    Jul, 10

    – Minneapolis, MN Transforming the Organ Tissue Model StemoniX Finds Billion-Cell Lots Enhance the Consistency of Toxicity Testing Operations The microHeart® and microBrain® microtissues developed by StemoniX overcome many of the challenges associated with tissues developed from human induced pluripotent stem cells (hiPSCs) to provide greater consistency and high degrees of functionality for high-throughput drug […]

    Read more
  • Jun, 17

    – Minneapolis, MN StemoniX chosen as a 2017 Red Herring Top 100 North America Winner Red Herring today announced the winners of its Top 100 North America 2017 event, recognizing the continent’s most exciting and innovative private technology companies. The winners, celebrated at a special awards ceremony at the Marina Del Rey Marriott Hotel, have […]

    Read more
    Feb, 8

    – Minneapolis, MN Cardiac Drug Toxicity and Discovery Screening Reaches New Relevance with Launch of microHeart® at SLAS2017 StemoniX® to release new data demonstrating how microHeart aligns cardiac cells into physiologically relevant structures, representing a breakthrough in powerful human iPSC screening platforms. Minneapolis-based StemoniX, Inc. will present research demonstrating superiority of their microHeart® microplates over […]

    Read more
  • Jan, 19

    – Minneapolis, MN Innovation AveNEW Program MINNEAPOLIS (WCCO) — Be sure to stop by the newly redesigned Innovation AveNEW in the SLAS2017 Exhibition to visit with these companies and see the technology which earned this important distinction. Innovation AveNEW is a traditional highlight of the annual SLAS Conference and Exhibition. Through this program, SLAS provides […]

    Read more
    Nov, 25

    – Minneapolis, MN Minnesotan To Meet: StemoniX CEO Ping Yeh MINNEAPOLIS (WCCO) — He beat cancer and now he’s trying to tackle other diseases head-on to help others do the same! That’s why Eden Prairie’s Ping Yeh started up the company StemoniX and it’s getting some positive attention. Yeh and the company’s co-founders are the […]

    Read more